Tambagel, Jenny Grace .
HRN: 20-23-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
CEFUROXIME 1.5GM (VIAL)
05/19/2022
05/19/2022
IV
1.5g
Loading Dose
G1P1 PROM 46h
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes